Rapports de recherche, comptes rendus, lettres à l'éditeur, working papers (16)
  1. 2. Coussement, J., & Dauby, N. (2021). Antibiotic treatment duration for bacteraemic pneumonia. Lancet, 398(10310), 1484-1485. doi:10.1016/S0140-6736(21)01735-9
  2. 3. Dauby, N. (2021). Favipiravir as an Antiviral Agent in Coronavirus Disease 2019 (COVID-19): Same Script, Different Cast? Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 73(3), e847-e848. doi:10.1093/cid/ciaa1600
  3. 4. Dauby, N., Hautekiet, J., Catteau, L., Montourcy, M., Van Beckhoven, D., Bottieau, E., & Goetghebeur, E. (2021). Reply to The perceived efficacy of hydroxychloroquine in observational studies: the results of the confounding effects of goals of care. International journal of antimicrobial agents, 57(4), 106307. doi:10.1016/j.ijantimicag.2021.106307
  4. 5. Dauby, N., Catteau, L., Hautekiet, J., Montourcy, M., Bottieau, E., Goetghebeur, E., & Van Beckhoven, D. (2021). Reply to ‘Low‐dose hydroxychloroquine therapy and lower mortality in hospitalized patients with COVID‐19: association does not mean causality’. International journal of antimicrobial agents, 57(2), 106261. doi:10.1016/j.ijantimicag.2020.106261
  5. 6. Dauby, N., & Bottieau, E. (2021). The unfinished story of hydroxychloroquine in COVID-19: The right anti-inflammatory dose at the right moment? International journal of infectious diseases, 103, 1-2. doi:10.1016/j.ijid.2020.10.032
  6. 7. Dauby, N., Van Praet, S., Vanhomwegen, C., Veliziotis, I., Konopnicki, D., & Roman, A. (2020). Tolerability of favipiravir therapy in critically ill patients with COVID-19: A report of four cases. Journal of medical virology, 93(2), 689-691. doi:10.1002/jmv.26488
  7. 8. Dauby, N. (2020). Potential impact of COVID-19 in people living with HIV: experience from previous 21st century coronaviruses epidemics. AIDS (London, England), 34(8), 1255-1256. doi:10.1097/QAD.0000000000002555
  8. 9. Dauby, N. (2020). Head and Neck Cancer. The New England journal of medicine, 382(20), e57. doi:10.1056/NEJMc2001370
  9. 10. Dauby, N. (2019). Perinatal HIV and response to vaccination. AIDS, 33(10), 1674-1675. doi:10.1097/QAD.0000000000002246
  10. 11. Dauby, N. (2019). Vaccination for the Prevention of Group B Streptococcus Infection in Nonpregnant Adults. JAMA Internal Medicine, 179(7), 998-999. doi:10.1001/jamainternmed.2019.1590
  11. 12. Dauby, N. (2017). Risks of Saccharomyces boulardii-Containing Probiotics for the Prevention of Clostridium difficile Infection in the Elderly. Gastroenterology, 153(5), 1450-1451. doi:10.1053/j.gastro.2017.04.054
  12. 13. Flores Herrera, M. M., & Dauby, N. (2017). Eye compartmentalization of HIV replication and cataract risk in HIV-infected patients: Is there a link? AIDS, 31(14), 2024-2025. doi:10.1097/QAD.0000000000001598
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 Suivant >>